GC
STAB

Guggenheim Capital’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Guggenheim Capital’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,177
Closed -$11K – 3158
2014
Q2 		$11K Sell
1,177
-118
-9% -$1.38K ﹤0.01% 3185
2014
Q1 		$18K Buy
1,295
+294
+29% +$4.79K ﹤0.01% 3239
2013
Q4 		$23K Buy
1,001
+59
+6% +$1.6K ﹤0.01% 3117
2013
Q3 		$29K Hold
942
– – ﹤0.01% 2992
2013
Q2 		$30K Buy
+942
New +$32.4K ﹤0.01% 2950

Other funds holding STAB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Guggenheim Capital's STAB Position: Q3 2014 in Review

Guggenheim Capital sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q3 2014, closing a stake of 1,177 shares — an estimated $11K sold.

Guggenheim Capital first reported a position in STAB in Q2 2013 and held it in 5 quarters. The position peaked at $30K in Q2 2013. 25 funds tracked by Wall St. Rank hold STAB as of Q3 2014.

  • Guggenheim Capital reported no remaining Statera Biopharma, Inc. Common Stock position as of Q3 2014 after selling out during the quarter.
  • Guggenheim Capital sold 1,177 Statera Biopharma, Inc. Common Stock shares in Q3 2014, an estimated $11K.
  • Guggenheim Capital first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2013 and held it in 5 quarters.
  • Guggenheim Capital's Statera Biopharma, Inc. Common Stock position peaked at $30K in Q2 2013.
  • 25 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q3 2014.

Based on Guggenheim Capital's 13F filing for Q3 2014, filed 14 Nov 2014.